Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
NCT01069692
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
115
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperphosphatemia
Chronic Kidney Disease
Interventions
DRUG:
SBR759A
DRUG:
SBR759A
DRUG:
SBR759A
DRUG:
SBR759A
DRUG:
SBR759A
Sponsor
Novartis